Varela VSM, González GM

Language: Spanish
References: 13
Page:
PDF size: 67.40 Kb.

ABSTRACT

The leprosy or Hansen's disease is a bacterial disease produced by Mycobacterium leprae, the fact that you affect the skin, the peripheral nerves principally and at times the respiratory superior roads. This bacillus is acid resistant alcohol and cannot grow neither in means for bacteria neither in cell cultivations. The human being is the principal guest and reservoir of the M leprae. Statuses reacciónales of the leprosy are intense episodes or that they take place in the course of the chronic evolution of the disease, as a result of the sudden activation of the cell immunity (reaction type 1), or of an inappropriate stimulation of immunity humoral (reaction type 2). Lepromatosa, that you began with exacerbation of the clinical picture, with plates infiltrated in trunk and inferior limbs, that 1 reciprocated with a leprous reaction type itself pretends to be a presentation of a clinical case, feminine, 24- years patient, with diagnosis of leprosy in the present-day investigation.

REFERENCES

1. Heymann DL. Control of Communicable Diseases Manual. 19ed. EE UU: APHA; 2008.

2. World Health Organization. Leprosy update, 2011. Weekly epidemiological record. 2011; 36(86):389-400.

3. Rodríguez E, Díaz O, Hernández G. Vigilancia de la lepra. Situación en el mundo y en España, 2010. Bol Epidemiol Semanal 2009; 18(21): 201-2.

4. Krutzi SR, Ochoa MT, Sieling PA. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med. 2003; 9: 525-32.

5. Bochud PY, Hawn TR, Aderem A. Cutting edge: A toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signalling. J Immnol. 2003; 170: 3451-54

6. Sieling PA, Wang XH, Gately MK. IL12 regulates T helper Type 1 cytokine responses in human infectious diseases. J Immunol. 1994; 153: 3639-47

7. Kim J, Uyemura K, Van Dike MK. A role for IL12 receptor expression and signal transdiction in host defense in leprosy. J Immunol. 2001; 167: 779-86.

8. Mohaghegpour N, Gelber RH, Larrick JW. Detective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patient to respond to Mycobacterium leprae associated with detective expression of interleukin-2 receptors and is not reconstituted by interleukin 2. J Immunol. 1985; 135: 1443-49.

9. Mutis T, Kraakman EM, Cornelisse YE. Analysis of citokine production by Mycobacterium –reactive T cells. J Immunol. 1993; 150: 4641-51.

10. Misra N, Murtaza A, Walter B. Citokine profile of circulating T cells in leprosy patients reflects both indiscriminated and polarized T-helper subsets. Immunol. 1995; 86: 97-103.

11. Fink S, Finíais M, Valdés R, Barrera S de la, Sasiaini MC. Evaluación de la producción de citoquinas en enfermos de lepra. Medicina (Buenos Aires). [Internet].1996 [citado 2014 mar 24]; 56(6):705-8. Disponible en: http://www.medicinabuenosaires.com/vol56 96/6producciondecitoquinas.htm.

12. Goularr I MB, Figueiredo F, Coimbra T, Foss N.T. Detection of transforming growth factor-beta 1 in thermal lesions of different clinical forms of leprosy. Am J Pathol.1996; 148: 911-17.

13. Rada E, Aranzazu N, Convit J. Ciertos aspectos inmunológicos en los estados reaccionales en la enfermedad de Hansen. Invest Clin. 2005; 46 (4): 381-389.